The Most Interesting Thing in A.I. Pharma's Future - with Nicholas Thompson, Diogo Rau and Dan Priest
Jun 11, 2025
In this engaging discussion, Diogo Rau, Executive Vice President at Eli Lilly, shares insights on how AI is revolutionizing drug discovery, making it quicker to find life-saving medications. Dan Priest, Chief AI Officer at PwC, explores the future of patient experiences through AI innovations. They delve into the benefits of personalized medicine, the adaptation of AI in healthcare, and the potential of collaborative AI to tackle global issues. Their foresight into the integration of advanced technologies promises an exciting transformation for the pharma industry.
AI Snips
Chapters
Transcript
Episode notes
Old College Emails Recalled
- Nicholas Thompson and Diogo Rao reconnected after 28 years recalling college emails about beer and music.
- This story humanizes the tech leaders behind AI-driven pharma innovation and shows long-term professional journeys.
Lilly's Bold AI Adoption
- Lilly embraced AI early, encouraging employees to experiment despite security concerns.
- Showing ChatGPT answers that matched hours of executive work sparked company-wide enthusiasm for AI.
AI Reads DNA Like Language
- AI models like large language models are effective for genetic medicines by interpreting DNA as language.
- This allows summarization and error detection in gene editing, speeding research in genetic therapies.